BSEInsider Trading / SAST3d ago · 22 Sept 2026, 03:05 pm
The Trading Window for dealing in shares of the Company shall remain closed for all designated persons including Promoters, Directors, KMPs and other Designated Employee and their connected persons from 1st October, 2026 , until 48 hours after the declaration of the unaudited financial results by the Company for quarter ending 30th September, 2026.
Indraprastha Medical Corporation Ltd · 532150
✦ AI Summary
Indraprastha Medical Corporation Ltd has closed its trading window for insiders from October 1, 2026, until 48 hours after the declaration of unaudited Q2 FY2026-27 results.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Indraprastha Medical Corporation Ltd - 532150 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
77be3ac6-67f8-44e5-9615-6c3925a0e702.pdf
View document text
Indraprastha Medical Corporation Limited
(Indraprastha Apollo Hospitals)
Regd. Office : Sarita Vihar, Delhi-Mathura Road, New Delhi – 110 076 (India)
Corporate Identity Number : L24232DL1988PLC030958
Phone:91-11-26925858,26925801,Fax: 91-11-26823629
E-mail: imclshares@apollohospitals.com, Website : https://www.apollohospitals.com/delhi/
Ref: IMCL/CS/TW/2026 22nd September, 2026
The Manager The Manager
Listing Department Listing Department
BSE Limited Phiroze Jeejeebhoy Towers National Stock Exchange of India Limited
Dalal Street, Mumbai, Maharashtra - Exchange Plaza, C-1, Block G,
400001 Bandra Kurla Complex, Bandra East,
Scrip Code: 532150 Mumbai, Maharashtra – 400051
Symbol: INDRAMEDCO
Dear Sir,
Pursuant to provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI
(Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that the trading
window for dealing in shares of the Company shall remain closed for all designated persons
including Promoters, Directors, Key Managerial Personnel, Designated Employees and their
connected persons from Thursday, 1st October, 2026, until 48 hours after the declaration of
the unaudited financial results by the Company, for quarter ending 30th September, 2026.
During the period of closure of Trading Window, the Permanent Account Number of all
designated persons and their connected persons will remain frozen for trade in securities of
the Company.
The date of the Board Meeting to consider and approve the unaudited financial results for
the quarter ending 30th September, 2026, will be intimated in due course.
This is for your information and record.
Thanking You,
Sincerely Yours,
For Indraprastha Medical Corporation Limited
Priya Ranjan
AVP – Corporate Affairs & Legal
(Company Secretary & Compliance Officer)